Innovative Sensor Technology That Makes Sense

Kanichi Research Services Ltd (Kanichi) is a knowledge-based company founded in July 2008 and based in Warrington in the UK. The Company core competence is developing custom-made electrodes and other bespoke electrochemical components for advanced sensor systems, including the detection of a range of chemical and biological molecules in air, breath and liquid media. Our particular focus is on breathomics.

Kanichi History

Kanichi have a track record in advanced materials and methods that open the door to improved technology. Current applications include medical diagnostics, electrophysiological sensors, detection of heavy metals, and DNA sensing. Kanichi’s technology uniquely allows a number of analytes to be measured from a single sample for example hydrogen, methane, carbon monoxide, as well as ammonia in breath.

Kanichi’s electrochemical and nanomaterial technology is commercialised to support advances in other rapidly emerging application areas such as trace component detection, highly conductive functionalised inks, radio frequency identification devices, fuel cells and printed thin film batteries. These technologies result in the development of a pipeline of products in life science and wider industry sectors.

Kanichi Sensors System

The Kanichi sensors system is in advanced development with our design partner, the system is comprised of a disposable, low cost, hand held breath condensate testing device with integrated ammonia sensor. A separate reader is available to display the test readings. The patient, before being given a standard urea test meal, breathes into the hand-held, disposable device for around 30 seconds after which the condensate interacts with the miniaturised electrode and a base ammonia reading is taken. 10 minutes after the urea meal, the patient repeats the test with a second single use device and a further reading of ammonia level is measured. The difference in readings indicates the presence of H. pylori and differential between the baseline and secondary reading producing a result that has a sensitivity and specificity of around 99%. As no laboratory testing is required, just a low cost, portable reusable reader, it is suitable for widespread use in developing countries providing real time results.

  • Point of care solution with results, no requirement for remote lab testing.
  • No collection and transport of gaseous samples to a laboratory with related costs and administration.
  • Ease of use, minimal training, suitable for pharmacy, nurse or remote clinic use.
  • High sensitivity and specificity to match current lab based 13C UBT test.
  • Low provider cost.
  • Suitable for widespread use in developing countries.
  • No need to buy an expensive capital equipment.
  • Immediate diagnosis and potential treatment therapy commencement No follow-up appointment or letter required.